Quality Compounder

556 tickers in this investment thesis
Ranks this page's recent reports by score.
Merck & Co., Inc.
MRK·Healthcare
B ★★★Hold
Current$149.52
Target$155.04
Return+3.7%
Nov 1, 2026

Merck combines a powerful oncology franchise, substantial cash generation, and a promising drug pipeline, but its valuation and dependence on successfully replacing future KEYTRUDA revenue limit the current margin of safety.

Score
67
Lincoln Electric Holdings, Inc.
LECO·Industrials
B ★★★Hold
Current$276.92
Target$294.17
Return+6.2%
Nov 1, 2026

Lincoln Electric combines leading welding technology, recurring consumables demand, and exceptional capital efficiency with growing automation opportunities, but its premium valuation leaves limited protection against an industrial slowdown.

Score
73
Yum China Holdings, Inc.
YUMC·Consumer Discretionary
S ★★★★★Strong Buy
Current$45.78
Target$56.95
Return+24.4%
Nov 1, 2026

Yum China's dominant restaurant network, improving profitability, and Pizza Hut ownership create attractive long-term compounding potential at a modest valuation, although Chinese consumer weakness and acquisition financing remain important risks.

Score
85
CSW Industrials, Inc.
CSW·Industrials
A ★★★★Buy
Current$286.16
Target$303.60
Return+6.1%
Nov 1, 2026

CSW Industrials combines specialized HVAC and building-product franchises with strong cash generation and acquisition-driven growth, but elevated leverage and post-acquisition capital returns constrain its margin of safety.

Score
76
Boot Barn Holdings, Inc.
BOOT·Consumer Discretionary
B ★★★Hold
Current$132.24
Target$161.50
Return+22.1%
Nov 1, 2026

Boot Barn can compound earnings through profitable nationwide western-workwear expansion and exclusive-brand growth, but modest same-store demand, capital-intensive expansion, and temporary margin benefits limit its margin of safety.

Score
74
Ambev S.A.
ABEV·Consumer Staples
S ★★★★★Strong Buy
Current$2.66
Target$3.00
Return+12.8%
Nov 1, 2026

Ambev combines dominant beverage brands, strong cash generation, and attractive valuation with meaningful shareholder returns, although Brazilian currency volatility and mature beer demand constrain its growth potential.

Score
86
KKR & Co. Inc.
KKR·Financials
A ★★★★Buy
Current$94.39
Target$112.00
Return+18.7%
Nov 1, 2026

KKR offers long-term compounding through expanding alternative assets, high-margin recurring fees and insurance integration at an attractive forward valuation, although credit losses and weak investment exits could impair earnings.

Score
82
Banco Bilbao Vizcaya Argentaria, S.A.
BBVA·Financials
B ★★★Hold
Current$23.44
Target$26.40
Return+12.6%
Nov 1, 2026

BBVA combines exceptional banking profitability, strong Mexican growth and substantial capital returns, but its historically elevated book valuation and emerging-market credit exposure limit the margin of safety.

Score
72
Anheuser-Busch InBev SA/NV
BUD·Consumer Staples
A ★★★★Buy
Current$80.38
Target$91.00
Return+13.2%
Nov 1, 2026

AB InBev combines global beer-brand leadership, strong cash generation, and improving shareholder returns, but mature beer demand, substantial leverage, and an elevated historical enterprise multiple constrain its upside.

Score
75
Hyatt Hotels Corporation
H·Consumer Discretionary
C ★★Sell
Current$180.57
Nov 1, 2026

Hyatt's premium hotel brands and growing asset-light fee platform offer attractive long-term cash-flow potential, but a demanding valuation and substantial leverage limit the margin of safety.

Score
58
Intercontinental Exchange, Inc.
ICE·Financials
S ★★★★★Strong Buy
Current$168.85
Target$193.20
Return+14.4%
Nov 1, 2026

ICE combines entrenched exchange network effects, recurring financial data revenue, and strong cash generation at an attractive valuation, although MarketAxess acquisition financing and integration introduce meaningful execution risk.

Score
86